CHK1 Inhibitors in Combination Chemotherapy
Figure 2
Radiation exposure and the activation of multiple signaling pathways
Activated signaling pathways act in balance and can promote both cell survival as well as cell death. The combination of inhibitors that block AKT/ERK1/2 activation with radiotherapy enhances activation of the toxic JNK/p38 pathways to cause tumor cell death.
